These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23482516)

  • 41. Magnesium status and association with diabetes in the Taiwanese elderly.
    Wang JL; Shaw NS; Yeh HY; Kao MD
    Asia Pac J Clin Nutr; 2005; 14(3):263-9. PubMed ID: 16169838
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cisplatin-induced injury of the renal distal convoluted tubule is associated with hypomagnesaemia in mice.
    van Angelen AA; Glaudemans B; van der Kemp AW; Hoenderop JG; Bindels RJ
    Nephrol Dial Transplant; 2013 Apr; 28(4):879-89. PubMed ID: 23136218
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of magnesium on phosphorus and calcium metabolism.
    Paunier L
    Monatsschr Kinderheilkd; 1992 Sep; 140(9 Suppl 1):S17-20. PubMed ID: 1331782
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypomagnesemia Following Prolonged Use of Proton-pump Inhibitors.
    Janett S; Bianchetti MG; Milani GP; Lava SA
    J Pediatr Gastroenterol Nutr; 2016 Apr; 62(4):e39. PubMed ID: 27010402
    [No Abstract]   [Full Text] [Related]  

  • 45. [Chronic use of proton-pump inhibitors associated with giardiasis: A rare cause of hypomagnesemic hypoparathyroidism?].
    François M; Lévy-Bohbot N; Caron J; Durlach V
    Ann Endocrinol (Paris); 2008 Nov; 69(5):446-8. PubMed ID: 18614153
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A case of hypomagnesaemia due to malabsorption, unresponsive to oral administration of magnesium glycerophosphate, but responsive to oral magnesium oxide supplementation.
    Ross JR; Dargan PI; Jones AL; Kostrzewski A
    Gut; 2001 Jun; 48(6):857-8. PubMed ID: 11358909
    [No Abstract]   [Full Text] [Related]  

  • 47. A case series of proton pump inhibitor-induced hypomagnesemia.
    Hoorn EJ; van der Hoek J; de Man RA; Kuipers EJ; Bolwerk C; Zietse R
    Am J Kidney Dis; 2010 Jul; 56(1):112-6. PubMed ID: 20189276
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Magnesium in kidney diseases. A review.
    Labeeuw M; Pozet N
    Magnes Res; 1988 Dec; 1(3-4):187-202. PubMed ID: 3079419
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renal responsiveness to magnesium and parathormone in primary familial hypomagnesaemia.
    Pronicka E; Sliwińska J; Gruszczyńska B; Wieczorek E; Klimaszewski J; Urbanek M
    Acta Med Pol; 1985; 26(1-2):37-42. PubMed ID: 4096262
    [No Abstract]   [Full Text] [Related]  

  • 50. Could proton pump inhibitors cause cancer?
    Rosch PJ
    Arch Intern Med; 2010 Oct; 170(19):1775-6. PubMed ID: 20975029
    [No Abstract]   [Full Text] [Related]  

  • 51. Tetany, hypomagnesemia, and proton-pump inhibitors.
    Famularo G; Minisola G; Bravi MC; Colucci P; Gasbarrone L
    Am J Med; 2012 Oct; 125(10):e7-8. PubMed ID: 22800870
    [No Abstract]   [Full Text] [Related]  

  • 52. Severe proton pump inhibitor-induced hypomagnesaemia in a mother and daughter.
    Eberhard J; Macdonald A; Cundy T
    Intern Med J; 2017 Mar; 47(3):341-342. PubMed ID: 28260262
    [No Abstract]   [Full Text] [Related]  

  • 53. Severe hypomagnesemia during long-term treatment with a proton pump inhibitor.
    Regolisti G; Cabassi A; Parenti E; Maggiore U; Fiaccadori E
    Am J Kidney Dis; 2010 Jul; 56(1):168-74. PubMed ID: 20493607
    [No Abstract]   [Full Text] [Related]  

  • 54. Short-term proton pump inhibitor treatment may cause hypomagnesaemia in critically ill patients - a pilot study.
    Krzych ŁJ; Łój P; Nowak T; Kazura W; Knapik P
    Acta Biochim Pol; 2017; 64(3):499-501. PubMed ID: 28651024
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Continuous magnesium infusions in the management of systemic anti-cancer therapy-related hypomagnesaemia.
    Mateo-Carrasco H; Kostrzynski O; Ndefo O; Stapley S; Davies E; Agarwal R
    Int J Clin Pharm; 2017 Aug; 39(4):657-661. PubMed ID: 28444546
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Magnesium and Drugs.
    Gröber U
    Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035385
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Causes and treatment of hypomagnesemia].
    Yamamoto M; Yamaguchi T
    Clin Calcium; 2007 Aug; 17(8):1241-8. PubMed ID: 17660622
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proton-pump inhibitor use is associated with lower urinary magnesium excretion.
    William JH; Nelson R; Hayman N; Mukamal KJ; Danziger J
    Nephrology (Carlton); 2014 Dec; 19(12):798-801. PubMed ID: 25142949
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The hypomagnesaemic action of FK506: urinary excretion of magnesium and calcium and the role of parathyroid hormone.
    Lote CJ; Thewles A; Wood JA; Zafar T
    Clin Sci (Lond); 2000 Oct; 99(4):285-92. PubMed ID: 10995593
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proton pump inhibitors and risk of hypomagnesemia.
    Pasina L; Zanotta D; Puricelli S; Djignefa DC; Bonoldi G
    Eur J Intern Med; 2015 Sep; 26(7):e25-6. PubMed ID: 26165831
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.